Sort
51,593 grants matching “hepatitis”
HBV Prevention for Homeless At-Risk for HBV/HCV/HIV
$791,514Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2006 · DA
Mechanisms of repeated control of acute hepatitis C infection in humans
$791,478Andrea L Cox · Johns Hopkins University · U19 · FY2016 · AI
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
$791,350Curt G Beckwith · Miriam Hospital · R01 · FY2010 · DA
Correlates of protective immunity to HCV and rational vaccine design: Project 2
$791,335Arash Grakoui · Emory University · U19 · FY2023 · AI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$791,318Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
FUNCTIONAL GENOMICS & VIROLOGY CORE
$791,307Michael G Katze · University Of Washington · P30 · FY2007 · DA
Pharmacogenetics of the Statin Response
$791,279Tufts University Boston · R01 · FY2004 · HL
Asian Community Cancer Health Disparities Center (ACCHDC)
$790,949Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2014 · CA
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$790,878Ashwin Balagopal · Johns Hopkins University · R01 · FY2020 · AI
Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing
$790,800George Norbert Cox · Bolder Biotechnology, Inc. · R44 · FY2009 · NS
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$790,717Ashwin Balagopal · Johns Hopkins University · R01 · FY2018 · AI
Treating flaviviruses with mRNA-encoded Cas13
$790,410Philip J Santangelo · Emory University · R01 · FY2024 · AI
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs
$790,403Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DA
Sample Processing and Analytical Methods Development for New Anticancer Agents
$790,209William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2014 · CA
Development of a charge detection mass spectrometer for the analysis ofgene therapy and other large pharmaceutical biologics
$790,055Benjamin E Draper · Megadalton Solutions, Inc · R44 · FY2020 · GM
Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy
$790,034Vincent Lo Re · University Of Pennsylvania · R01 · FY2020 · AI
Understanding the Regional Ecology of a Future HIV Vaccine
$790,033Dolores Albarracin · University Of Pennsylvania · R01 · FY2024 · MH
NIH Director's Pioneer Award
$790,000Karla Kirkegaard · Stanford University · DP1 · FY2009 · OD
NIH Director's Pioneer Award
$790,000Karla Kirkegaard · Stanford University · DP1 · FY2010 · OD
NIH Director's Pioneer Award
$790,000Karla Kirkegaard · Stanford University · DP1 · FY2008 · OD
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
$789,648Michael Agus · Boston Children'S Hospital · R01 · FY2010 · HL
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$789,531Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network
$789,514T John Winhusen · University Of Cincinnati · UG1 · FY2015 · DA
Hepatitis C: Studies of Immunity and Pathogenesis
$789,384Charles M. Rice · Rockefeller University · U19 · FY2007 · AI
NIH Director's Pioneer Award
$789,375Karla Kirkegaard · Stanford University · DP1 · FY2007 · OD